课题基金 / 基金详情

项目摘要

项目成果

Haodong Xu的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):
英文摘要
DESCRIPTION (provided by applicant): This proposal describes a 5-year training program for the development of an academic career in molecular cardiac electropathophysiology. The principal investigator is a pathologist with an expertise in cardiac electrophysiology and cardiopulmonary pathology, and through this program he will expand upon his scientific and investigative skills. The Cardiovascular Research Institute of the University of Rochester Medical Center will provide the principal investigator with an ideal setting for studying the molecular mechanisms involved in cardiac dysrhythmias under the expert guidance of experienced mentor Dr. Jun-lchi Abe and committee members Drs. Bradford Berk and Mark Taubman, and with additional support from consultants Drs. Jose Jalife and Robert Dirksen. The proposal focuses on the role of the p90 Ribosomal S6 Kinase (p90RSK) in cardiac dysrhythmias, which are a leading cause of morbidity and mortality in different types of heart disease. Based on the preliminary data, the experimental hypothesis is that activation of pQORSK reduces lto,f channel activity via phosphorylation of Kv4.3, prolongs cardiac repolarization, and predisposes to dysrhythmias in cardiac disease. To investigate the role of modulation of It0.f by p90RSK in cardiac dysrhythmias three specific aims are proposed: 1) Determine the molecular mechanism by which lto,f is modulated by p90RSK. 2) Determine the molecular mechanism by which activation of p90RSK prolongs action potential duration and predisposes to dysrhythmias via inhibition of lto,f channel activity. 3) Determine if perturbing p90RSK signaling reduces frequency of dysrhythmias induced by cardiac ischemia/reperfusion and myocardial infarction via preventing downregulation of lto,f channel activity. Irregular heart rhythms are a common cause of morbidity and mortality in patients with heart disease This research will investigate the effects of the protein p90 Ribosomal S6 Kinase on heart rhythms. The results of these studies will enhance our knowledge of the molecular basis of these abnormalities and could lead to development of new therapies for their treatment and/or prevention. (End of Abstract)
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.carpath.2015.10.010
发表时间: 2016-03
期刊: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
影响因子: --
作者: [Ye B, Hou N, Xiao L, Xu Y, Xu H, Li F]
通讯作者: Li F
DOI: 10.1016/j.yjmcc.2014.06.006
发表时间: 2014-09
期刊: JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
影响因子: 5
作者: [Cai, Benzhi, Wang, Ning, Mao, Weike, You, Tao, Lu, Yan, Li, Xiang, Li, Faqian, Xu, Haodong]
通讯作者: Xu, Haodong
Canonical Wnt/β-catenin signaling in epicardial fibrosis of failed pediatric heart allografts with diastolic dysfunction.
伴有舒张功能障碍的失败儿科同种异体心脏移植物心外膜纤维化中的典型 Wnt/β-连环蛋白信号传导。
DOI: 10.1016/j.carpath.2012.03.004
发表时间: 2013-01
期刊: CARDIOVASCULAR PATHOLOGY
影响因子: 3.7
作者: [Ye, Bo, Ge, Yao, Perens, Gregory, Hong, Longsheng, Xu, Haodong, Fishbein, Michael C., Li, Faqian]
通讯作者: Li, Faqian
DOI: 10.3892/ijmm.2015.2223
发表时间: 2015-07
期刊: International journal of molecular medicine
影响因子: 5.4
作者: [You T, Mao W, Cai B, Li F, Xu H]
通讯作者: Xu H
Role of the ATP-dependent chromatin-remodeling enzyme Brg1 in the regulation of cardiac Na+ channel
Role of the ATP-dependent chromatin-remodeling enzyme Brg1 in the regulation of cardiac Na+ channel
  • 批准号:
    10705353
  • 项目类别:
  • 资助金额:
    $5.79万
  • 财政年份:
    2022
  • 负责人:
    Haodong Xu
  • 依托单位:
Core 2: Histopathology and Biospecimen Core
  • 批准号:
    10700910
  • 项目类别:
  • 资助金额:
    $21.28万
  • 财政年份:
    2019
  • 负责人:
    Haodong Xu
  • 依托单位:
Wnt/beta-cantenin signaling and cardiac ion channels
海外基金